Bachem Holding AG Bachem Holding AG

Bachem Holding AG

BANB

株式のランク #2516
Bachem Holding AG serves pharmaceutical and biotechnology companies globally,... Bachem Holding AG serves pharmaceutical and biotechnology companies globally, providing products crucial for research, clinical development, and commercial use. The company's primary focus is on the design, manufacturing, and regulatory support for peptide active pharmaceutical ingredients (APIs), specifically targeting novel peptide and oligonucleotide chemical entities (NCEs). Additionally, Bachem offers commercially available NCEs and generic compounds. Its comprehensive service portfolio includes project management, quality assurance and regulatory guidance, analytical testing, production adhering to Good Manufacturing Practices (GMP), manufacturing for research purposes, and expertise in supply chain and vertical integration. Established in 1971, Bachem Holding AG is headquartered in Bubendorf, Switzerland, and functions as a subsidiary of Ingro Finanz AG.
株価
$100.60
時価総額
$7.54B
変化(1日)
-1.49%
変化(1年)
49.53%
国
CH
取引 Bachem Holding AG (BANB)

カテゴリー

Healthcare
Bachem Holding AG(BANB)の配当利回りの履歴
Bachem Holding AG(銘柄コード: BANB)の配当利回り(TTM)は2024-12-31時点で1.38%です。
過去5年間の平均配当利回り: 0.86%
Bachem Holding AG(BANB)の2002から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
年 配当利回り 変化
2026 (TTM) 1.08% 58.82%
2025 0.68% -50.72%
2024 1.38% 18.97%
2023 1.16% 31.82%
2022 0.88% 340.00%
2021 0.20% -73.68%
2020 0.76% -40.63%
2019 1.28% -27.27%
2018 1.76% 53.04%
2017 1.15% -31.14%
2016 1.67% -31.28%
2015 2.43% -31.93%
2014 3.57% 15.53%
2013 3.09% 50.73%
2012 2.05% -46.19%
2011 3.81% 43.77%
2010 2.65% 11.34%
2009 2.38% -36.36%
2008 3.74% -48.84%
2007 7.31% 348.47%
2006 1.63% 409.38%
2005 0.32% -81.07%
2004 1.69% -92.16%
2003 21.55% -99.40%
2002 3,618.76% 0.00%
類似企業または競合他社の配当利回り(TTM)